Literature DB >> 22763983

Analysis of high-throughput screening assays using cluster enrichment.

Minya Pu1, Tomoko Hayashi, Howard Cottam, Joseph Mulvaney, Michelle Arkin, Maripat Corr, Dennis Carson, Karen Messer.   

Abstract

In this paper, we describe the implementation and evaluation of a cluster-based enrichment strategy to call hits from a high-throughput screen using a typical cell-based assay of 160,000 chemical compounds. Our focus is on statistical properties of the prospective design choices throughout the analysis, including how to choose the number of clusters for optimal power, the choice of test statistic, the significance thresholds for clusters and the activity threshold for candidate hits, how to rank selected hits for carry-forward to the confirmation screen, and how to identify confirmed hits in a data-driven manner. Whereas previously the literature has focused on choice of test statistic or chemical descriptors, our studies suggest that cluster size is the more important design choice. We recommend clusters to be ranked by enrichment odds ratio, not by p-value. Our conceptually simple test statistic is seen to identify the same set of hits as more complex scoring methods proposed in the literature do. We prospectively confirm that such a cluster-based approach can outperform the naive top X approach and estimate that we improved confirmation rates by about 31.5% from 813 using the top X approach to 1187 using our cluster-based method.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22763983      PMCID: PMC3635947          DOI: 10.1002/sim.5455

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  20 in total

1.  Analysis of a large structure/biological activity data set using recursive partitioning.

Authors:  A Rusinko; M W Farmen; C G Lambert; P L Brown; S S Young
Journal:  J Chem Inf Comput Sci       Date:  1999 Nov-Dec

2.  Compound set enrichment: a novel approach to analysis of primary HTS data.

Authors:  Thibault Varin; Hanspeter Gubler; Christian N Parker; Ji-Hu Zhang; Pichai Raman; Peter Ertl; Ansgar Schuffenhauer
Journal:  J Chem Inf Model       Date:  2010-11-12       Impact factor: 4.956

3.  Novel statistical approach for primary high-throughput screening hit selection.

Authors:  S Frank Yan; Hayk Asatryan; Jing Li; Yingyao Zhou
Journal:  J Chem Inf Model       Date:  2005 Nov-Dec       Impact factor: 4.956

4.  Using extended-connectivity fingerprints with Laplacian-modified Bayesian analysis in high-throughput screening follow-up.

Authors:  David Rogers; Robert D Brown; Mathew Hahn
Journal:  J Biomol Screen       Date:  2005-09-16

5.  Enrichment of high-throughput screening data with increasing levels of noise using support vector machines, recursive partitioning, and laplacian-modified naive bayesian classifiers.

Authors:  Meir Glick; Jeremy L Jenkins; James H Nettles; Hamilton Hitchings; John W Davies
Journal:  J Chem Inf Model       Date:  2006 Jan-Feb       Impact factor: 4.956

6.  An ultraefficient affinity-based high-throughout screening process: application to bacterial cell wall biosynthesis enzyme MurF.

Authors:  Kenneth M Comess; Mark E Schurdak; Martin J Voorbach; Michael Coen; Jonathan D Trumbull; Houjun Yang; Lan Gao; Hua Tang; Xueheng Cheng; Claude G Lerner; J Owen McCall; David J Burns; Bruce A Beutel
Journal:  J Biomol Screen       Date:  2006-09-14

7.  A probability-based approach for the analysis of large-scale RNAi screens.

Authors:  Renate König; Chih-yuan Chiang; Buu P Tu; S Frank Yan; Paul D DeJesus; Angelica Romero; Tobias Bergauer; Anthony Orth; Ute Krueger; Yingyao Zhou; Sumit K Chanda
Journal:  Nat Methods       Date:  2007-09-09       Impact factor: 28.547

8.  A support vector machines approach for virtual screening of active compounds of single and multiple mechanisms from large libraries at an improved hit-rate and enrichment factor.

Authors:  L Y Han; X H Ma; H H Lin; J Jia; F Zhu; Y Xue; Z R Li; Z W Cao; Z L Ji; Y Z Chen
Journal:  J Mol Graph Model       Date:  2007-12-15       Impact factor: 2.518

9.  Enhanced HTS hit selection via a local hit rate analysis.

Authors:  Bruce A Posner; Hualin Xi; James E J Mills
Journal:  J Chem Inf Model       Date:  2009-10       Impact factor: 4.956

Review 10.  Review article: high-throughput affinity-based technologies for small-molecule drug discovery.

Authors:  Zhengrong Zhu; John Cuozzo
Journal:  J Biomol Screen       Date:  2009-12
View more
  10 in total

1.  Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.

Authors:  Peter H Goff; Tomoko Hayashi; Luis Martínez-Gil; Maripat Corr; Brian Crain; Shiyin Yao; Howard B Cottam; Michael Chan; Irene Ramos; Dirk Eggink; Mitra Heshmati; Florian Krammer; Karen Messer; Minya Pu; Ana Fernandez-Sesma; Peter Palese; Dennis A Carson
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

2.  Structure-Activity Relationship Studies of Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands.

Authors:  Michael Chan; Yuhei Kakitsubata; Tomoko Hayashi; Alast Ahmadi; Shiyin Yao; Nikunj M Shukla; Shin-Ya Oyama; Akihito Baba; Brandon Nguyen; Maripat Corr; Yasuo Suda; Dennis A Carson; Howard B Cottam; Masahiro Wakao
Journal:  J Med Chem       Date:  2017-11-03       Impact factor: 7.446

3.  Identification of Biologically Active Pyrimido[5,4-b]indoles That Prolong NF-κB Activation without Intrinsic Activity.

Authors:  Michael Chan; Alast Ahmadi; Shiyin Yao; Fumi Sato-Kaneko; Karen Messer; Minya Pu; Brandon Nguyen; Tomoko Hayashi; Maripat Corr; Dennis A Carson; Howard B Cottam; Nikunj M Shukla
Journal:  ACS Comb Sci       Date:  2017-07-13       Impact factor: 3.784

4.  Small Molecule Calcium Channel Activator Potentiates Adjuvant Activity.

Authors:  Tetsuya Saito; Nikunj M Shukla; Fumi Sato-Kaneko; Yukiya Sako; Tadashi Hosoya; Shiyin Yao; Fitzgerald S Lao; Karen Messer; Minya Pu; Michael Chan; Paul J Chu; Howard B Cottam; Tomoko Hayashi; Dennis A Carson; Maripat Corr
Journal:  ACS Chem Biol       Date:  2022-01-05       Impact factor: 5.100

5.  Discovery of substituted 4-aminoquinazolines as selective Toll-like receptor 4 ligands.

Authors:  Afshin Nour; Tomoko Hayashi; Michael Chan; Shiyin Yao; Rommel I Tawatao; Brian Crain; Igor F Tsigelny; Valentina L Kouznetsova; Alast Ahmadiiveli; Karen Messer; Minya Pu; Maripat Corr; Dennis A Carson; Howard B Cottam
Journal:  Bioorg Med Chem Lett       Date:  2014-09-22       Impact factor: 2.823

6.  Identification of substituted pyrimido[5,4-b]indoles as selective Toll-like receptor 4 ligands.

Authors:  Michael Chan; Tomoko Hayashi; Richard D Mathewson; Afshin Nour; Yuki Hayashi; Shiyin Yao; Rommel I Tawatao; Brian Crain; Igor F Tsigelny; Valentina L Kouznetsova; Karen Messer; Minya Pu; Maripat Corr; Dennis A Carson; Howard B Cottam
Journal:  J Med Chem       Date:  2013-05-24       Impact factor: 7.446

7.  InCHlib - interactive cluster heatmap for web applications.

Authors:  Ctibor Skuta; Petr Bartůněk; Daniel Svozil
Journal:  J Cheminform       Date:  2014-09-17       Impact factor: 5.514

8.  A Triple High Throughput Screening for Extracellular Vesicle Inducing Agents With Immunostimulatory Activity.

Authors:  Nikunj M Shukla; Fumi Sato-Kaneko; Shiyin Yao; Minya Pu; Michael Chan; Fitzgerald S Lao; Yukiya Sako; Tetsuya Saito; Karen Messer; Tomoko Hayashi; Howard B Cottam; Maripat Corr; Dennis A Carson
Journal:  Front Pharmacol       Date:  2022-04-11       Impact factor: 5.988

9.  Identification of Compounds That Prolong Type I Interferon Signaling as Potential Vaccine Adjuvants.

Authors:  Nikunj M Shukla; Kei-Ichiro Arimoto; Shiyin Yao; Jun-Bao Fan; Yue Zhang; Fumi Sato-Kaneko; Fitzgerald S Lao; Tadashi Hosoya; Karen Messer; Minya Pu; Howard B Cottam; Dennis A Carson; Tomoko Hayashi; Dong-Er Zhang; Maripat Corr
Journal:  SLAS Discov       Date:  2018-05-11       Impact factor: 3.341

Review 10.  Early Probe and Drug Discovery in Academia: A Minireview.

Authors:  Anuradha Roy
Journal:  High Throughput       Date:  2018-02-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.